|1.||Potter, Lincoln R: 2 articles (04/2011 - 02/2006)|
|2.||Narumi, Satoshi: 1 article (04/2014)|
|3.||Amano, Naoko: 1 article (04/2014)|
|4.||Mukai, Tokuo: 1 article (04/2014)|
|5.||Yokoya, Susumu: 1 article (04/2014)|
|6.||Hasegawa, Tomonobu: 1 article (04/2014)|
|7.||Ito, Yoshiya: 1 article (04/2014)|
|8.||Tanaka, Toshiaki: 1 article (04/2014)|
|9.||Ogata, Tsutomu: 1 article (04/2014)|
|10.||Choi, In Ho: 1 article (01/2014)|
01/01/2012 - "Mutations in the gene NPR2 have been shown to cause acromesomelic dysplasia-type Maroteaux (AMDM), an autosomal recessive skeletal disproportionate dwarfism disorder in humans. "
04/01/2011 - "Inactivating mutations in GC-B cause acromesomelic dysplasia type Maroteaux dwarfism and chromosomal mutations that increase CNP concentrations are associated with Marfanoid-like skeletal overgrowth. "
11/05/1987 - "The preserved skeletal elements show that this individual (Romito 2) had the skull and long-bone morphology consistent with a mesomelic form of dwarfism, most probably the autosomal recessive disorder acromesomelic dysplasia. "
01/15/2009 - "Mutations in NPR-B have been shown to cause acromesomelic dysplasia-type Maroteaux (AMDM), a growth disorder in humans and severe dwarfism in mice. "
02/01/2006 - "Single allele-inactivating mutations in the promoter of human NPR-A are associated with hypertension and heart failure, whereas homozygous inactivating mutations in human NPR-B cause a form of short-limbed dwarfism known as acromesomelic dysplasia type Maroteaux. "
|2.||Genetic Translocation (Chromosomal Translocation)
01/01/2014 - "Loss of function mutations at NPR2 cause acromesomelic dysplasia, type Maroteaux, while overproduction of CNP by chromosomal translocation and a gain-of-function mutation at NPR2 have been reported to be responsible for an overgrowth syndrome in three cases and one family, respectively. "
|3.||Syringomyelia (Morvan's Disease)
|4.||Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
|1.||Fibular hypoplasia and complex brachydactyly